Methods to improve resectability of hepatocellular carcinoma

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 57-67

  Brouquet, Antoine ^a   Andreou, Andreas ^a   Shindoh, Junichi ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; SORAFENIB;

ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHRONIC LIVER DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SEVERITY; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER RESECTION; LIVER VEIN; LIVER WEIGHT; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PORTAL VEIN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 84868332176     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_4     Document Type: Article

References (32)

1. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699 (Pubitemid 26079803)
2. Yao FY, Bass NM, Nikolai B et al (2002) Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 8:873-883 (Pubitemid 35154015)
3. Pawlik TM, Esnaola NF, Vauthey JN (2004) Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl 10:S74-80 (Pubitemid 38240105)
4. Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512-529
5. Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321-328 (Pubitemid 43327762)
6. Kim SH, Lee WJ, Lim HK et al (2009) SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings. Korean J Radiol 10:112-120
7. Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908-1916 (Pubitemid 351783260)
8. Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298-304 (Pubitemid 23216368)
9. Kishi Y, Abdalla EK, Chun YS et al (2009) Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 250:540-548
10. Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274-286 (Pubitemid 46423843)
11. Truty MJ, Vauthey JN (2010) Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Semin Oncol 37:102-109
12. Farges O, Belghiti J, Kianmanesh R et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208-217 (Pubitemid 38173248)
13. Ribero D, Abdalla EK, Madoff DC et al (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94:1386-1394 (Pubitemid 350144388)
14. Luo YQ, Wang Y, Chen H et al (2002) Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 1:523-526 (Pubitemid 36748235)
15. Harada T, Matsuo K, Inoue T et al (1996) Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma. Ann Surg 224:4-9 (Pubitemid 26227401)
16. Sasaki A, Iwashita Y, Shibata K et al (2006) Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 32:773-779 (Pubitemid 44276006)
17. Zhou WP, Lai EC, Li AJ et al (2009) A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249:195-202
18. Aoki T, Imamura H, Hasegawa K et al (2004) Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 139:766-774 (Pubitemid 38886514)
19. Ogata S, Belghiti J, Farges O et al (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93:1091-1098 (Pubitemid 44343506)
20. Yoo H, Kim JH, Ko GY et al (2011) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 18:1251-1257
21. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390
22. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, doubleblind, placebo-controlled trial. Lancet Oncol 10:25-34
23. Salem R, Lewandowski RJ, Kulik L et al (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140:e492 (497-507)
24. Regimbeau JM, Farges O, Shen BY et al (1999) Is surgery for large hepatocellular carcinoma justified?. J Hepatol 31:1062-1068
25. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519-524 (Pubitemid 34183954)
26. Young AL, Malik HZ, Abu-Hilal M et al (2007) Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg 205:453-462 (Pubitemid 47314300)
27. Pawlik TM, Poon RT, Abdalla EK et al (2005) Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450-457
28. Ng KK, Vauthey JN, Pawlik TM et al (2005) Is hepatic resection for large or multinodular hepatocellular carcinoma justified?. Results from a multi-institutional database. Ann Surg Oncol 12:364-373
29. Ikai I, Yamamoto Y, Yamamoto N, et al (2003) Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg oncol clin North Am 12(1):65-75. (Pubitemid 36204980)
30. Shimada M, Takenaka K, Kawahara N et al (1996) Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery 119:517-522 (Pubitemid 26141027)
31. Poon RT, Fan ST (2003). Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surgical oncology clinics of North America 12:35-50, viii. (Pubitemid 36204978)
32. Pawlik TM, Poon RT, Abdalla EK et al (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403-410 (Pubitemid 40432037)